Related references
Note: Only part of the references are listed.Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I
Dorota Rowczenio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study
Donna E. Reece et al.
BLOOD (2011)
Renal function and mortality following cardiac resynchronization therapy
Grace Lin et al.
EUROPEAN HEART JOURNAL (2011)
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects
S. W. Dubrey et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Immunoglobulin Free Light Chain Dimers in Human Diseases
Batia Kaplan et al.
THESCIENTIFICWORLDJOURNAL (2011)
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs
Angela Dispenzieri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Solid Organ Transplantation in AL Amyloidosis
P. T. Sattianayagam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation
Arie J. Stangou et al.
BLOOD (2010)
Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis
Vaishali Sanchorawala et al.
BLOOD (2010)
Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis
Umit Tapan et al.
BLOOD (2010)
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
Philippe Moreau et al.
BLOOD (2010)
Systemic amyloidosis: getting to the heart of the matter
Philip N. Hawkins
BRITISH JOURNAL OF HOSPITAL MEDICINE (2010)
Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation
Jason D. Roberts et al.
EUROPACE (2010)
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
Efstathios Kastritis et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Karl Bodin et al.
NATURE (2010)
Liver transplantation for familial amyloid polyneuropathy
David Adams et al.
PRESSE MEDICALE (2010)
Amyloid Heart Disease
Rodney H. Falk et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Outcomes of Heart Transplantation for Cardiac Amyloidosis: Subanalysis of the Spanish Registry for Heart Transplantation
E. Roig et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide
Giovanni Palladini et al.
ANNALS OF HEMATOLOGY (2009)
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis
Arnt V. Kristen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis
Julian D. Gillmore et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Liver Transplantation for Familial Amyloidotic Polyneuropathy: Impact on Swedish Patients' Survival
Sadahisa Okamoto et al.
LIVER TRANSPLANTATION (2009)
Spotlight focuses on protein-misfolding therapies
Mark Ratner
NATURE BIOTECHNOLOGY (2009)
A preemptive combined liver-kidney transplantation in Aα fibrinogen chain renal amyloidosis
Jean-Philippe Delabre et al.
NEPHROLOGIE & THERAPEUTIQUE (2009)
Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings
Waldemar Hosch et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2008)
Heart transplantation in systemic (AL) amyloidosis: A retrospective study of eight French patients
Aude Mignot et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2008)
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone
D. Lebovic et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Yoshiki Sekijima et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis
Falk-Udo Sack et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis
Aude Mignot et al.
HAEMATOLOGICA (2008)
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
Ashutosh D. Wechalekar et al.
HAEMATOLOGICA (2008)
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death
Arnt V. Kristen et al.
HEART RHYTHM (2008)
Evaluation of Myocardial Changes in Familial Amyloid Polyneuropathy after Liver Transplantation
Sadahisa Okamoto et al.
INTERNAL MEDICINE (2008)
Autologous stem cell transplant after heart transplant for light chain (AL) amyloid cardiomyopathy
Martha Q. Lacy et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation
Ayako Tsuchiya et al.
LIVER TRANSPLANTATION (2008)
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation
Denice M. Hodgson-Zingman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation
Juris J. Liepnieks et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response
Morie A. Gertz et al.
HAEMATOLOGICA (2007)
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis:: results of a phase II trial
Adam D. Cohen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
Arnaud Jaccard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis
Giovanni Palladini et al.
BLOOD (2007)
Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein Al Gly26Arg: Outcome of hepatorenal transplantation
Adam G. Testro et al.
LIVER TRANSPLANTATION (2007)
Combined heart and liver transplantation for familial amyloidotic neuropathy
Emanuele Pilato et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Natural history and outcome in systemic AA amyloidosis
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human plasma fibrinogen is synthesized in the liver
Glenys A. Tennent et al.
BLOOD (2007)
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial
Vaishali Sanchorawala et al.
BLOOD (2007)
Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients
M. Yazaki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Organ transplantation in hereditary apolipoprotein Al amyloidosis
J. D. Gillmore et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy
Naomi Sakashita et al.
PATHOLOGY INTERNATIONAL (2006)
Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera
Brian O'Nuallain et al.
JOURNAL OF IMMUNOLOGY (2006)
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
Giovanni Palladini et al.
BLOOD (2006)
Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis
JD Gillmore et al.
BLOOD (2006)
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses
SM Johnson et al.
ACCOUNTS OF CHEMICAL RESEARCH (2005)
Outcome of heart transplantation in patients with amyloid cardiomyopathy
J Kpodonu et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
V Sanchorawala et al.
BONE MARROW TRANSPLANTATION (2005)
Diagnosis and management of the cardiac amyloidoses
RH Falk
CIRCULATION (2005)
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
MA Gertz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation
AJ Stangou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)
G Palladini et al.
BLOOD (2005)
Domino liver transplantation in living donors
Y Hashikura et al.
TRANSPLANTATION PROCEEDINGS (2005)
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
G Palladini et al.
BLOOD (2004)
Cardiac transplantation for amyloid heart disease: The United Kingdom experience
SW Dubrey et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2004)
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis
A Dispenzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Liver transplantation in transthyretin-related familial amyloid polyneuropathy
AJ Stangou et al.
CURRENT OPINION IN NEUROLOGY (2004)
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants
SR Miller et al.
LABORATORY INVESTIGATION (2004)
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis
A Dispenzieri et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
Combined heart and liver transplantation for familial amyloidotic neuropathy: Considerations from the hepatic point of view
GL Grazi et al.
LIVER TRANSPLANTATION (2003)
Tabulation of human transthyretin (TTR) variants, 2003
LH Connors et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
HJ Lachmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins
A Dispenzieri et al.
LANCET (2003)
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis
DC Seldin et al.
CLINICAL LYMPHOMA (2003)
Outcome of liver transplantation for familial amyloidotic polyneuropathy
P Sharma et al.
LIVER TRANSPLANTATION (2003)
Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type)
OB Suhr et al.
LIVER TRANSPLANTATION (2002)
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
MB Pepys et al.
NATURE (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors
VB Oza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil
PL Bittencourt et al.
LIVER TRANSPLANTATION (2002)
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
JD Gillmore et al.
LANCET (2001)
Livers from patients with apolipoprotein A-I amyloidosis are not suitable as domino donors
BH Shaz et al.
MODERN PATHOLOGY (2001)
Antibody-mediated resolution of light chain-associated amyloid deposits
R Hrncic et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
M Yazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family
JD Gillmore et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2000)
Share Paper
